CLOs on the Move

Incyte

www.incyte.com

 
Incyte is a biopharmaceutical company focused on the discovery, development and commercialization of innovative medicines that will meet serious unmet medical needs in oncology and other diseases. Incyte is a company driven by innovation, and we believe that investment in cutting-edge science and the rigorous pursuit of R&D excellence can translate into new medicines for serious unmet medical needs that positively impact patients` lives. Incyte has a diverse and growing portfolio of first-in-class and best-in-class product candidates, including both small and large molecules. Incyte is headquartered in Wilmington, Delaware with operations in 10 European countries and Japan. Our more than ...
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.incyte.com
  • 1801 Augustine Cut-off
    Wilmington, DE USA 19880
  • Phone: 855.446.2983

Executives

Name Title Contact Details
Pamela Politis
 Associate Vice President, North American Legal Profile
Sarah diFrancesca
 Executive Director of Compliance, Dermatolgy Lead Profile
Scott Larsen
 Vice President, IP Profile
Stephen Ferenchick
 Executive Director, Corporate Counsel Profile
Paul Quinones
 Vice President, Corporate Counsel, Development Profile

Similar Companies

Werewolf Therapeutics

Werewolf Therapeutics, Inc. is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body`s immune system for the treatment of cancer. We are leveraging our proprietary PREDATOR™ platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Our INDUKINE™ molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment. Our most advanced product candidates, WTX-124 and WTX-330, are systemically delivered, conditionally activated Interleukin-2 (IL-2) and Interleukin-12 (IL-12) INDUKINE molecules for the treatment of solid tumors. We are continuing preclinical studies for both WTX-124 and WTX-330 and expect to advance each candidate in multiple tumor types as a single agent and in combination with an immune checkpoint inhibitor.

Pharmathen

Pharmathen is a Hammond, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Arrowhead Research

Arrowhead Research Corporation is a biopharmaceutical company developing targeted RNAi therapeutics. The company is leveraging its proprietary Dynamic Polyconjugate delivery platform to develop targeted drugs based on the RNA interference mechanism that efficiently silences disease-causing genes. Arrowhead`s pipeline includes ARC-520 for chronic hepatitis B virus, ARC-AAT for liver disease associated with Alpha-1 antitrypsin deficiency, and partner-based programs in obesity and oncology.

Ventana Medical Systems

Ventana Medical Systems is a Tucson, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Phosplatin Therapeutics

Phosplatin Therapeutics is a private, clinical stage biopharmaceutical company founded in 2010, and funded by private investors and family investment offices in the U.S., Europe and Asia.